Dave L Roelen - JoVE Visualize

Showing results (41-50 of 137) with videos related to

Pageof 14

Sort By:

Transplantation|July 17, 2004

HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitroMarlies K A Dankers, Martin B A Heemskerk, Rene J Duquesnoy, et al.

Methods in Molecular Biology (Clifton, N.J.)|June 6, 2012

Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-transfected K562 cellsLloyd J D'Orsogna, Ellen M W van der Meer-Prins, Yvonne M Zoet, et al.

Human Immunology|May 29, 2003

Differential immunogenicity of paternal HLA Class I antigens in pregnant womenMarlies K A Dankers, Dave L Roelen, Nelleke Korfage, et al.

Annals of the Rheumatic Diseases|August 14, 2012

Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitisFloris A van Gaalen, Willem Verduijn, Dave L Roelen, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2022

Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot StudyAnnelies E de Weerd, Zainab Al Fatly, Marieken Boer-Verschragen, et al.

Frontiers in Genetics|November 1, 2023

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactionsLisanne E N Manson, Sander J Delwig, Jos J M Drabbels, et al.

Human Immunology|January 1, 2004

The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigensMarlies K A Dankers, Dave L Roelen, Nico J D Nagelkerke, et al.

Clinical Science (London, England : 1979)|December 15, 2007

Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysmJan H N Lindeman, Hazem Abdul-Hussien, Alexander F M Schaapherder, et al.

HLA|February 26, 2023

HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapySuzanne Bezstarosti, Soufian Meziyerh, Marlies E J Reinders, et al.

Transplantation|November 20, 2002

Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failureCorine A van Kampen, Dave L Roelen, Minke F J Versteeg-van der Voort Maarschalk, et al.

Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:

Pageof 14

Transplantation|July 17, 2004

HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitroMarlies K A Dankers, Martin B A Heemskerk, Rene J Duquesnoy, et al.

Methods in Molecular Biology (Clifton, N.J.)|June 6, 2012

Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-transfected K562 cellsLloyd J D'Orsogna, Ellen M W van der Meer-Prins, Yvonne M Zoet, et al.

Human Immunology|May 29, 2003

Differential immunogenicity of paternal HLA Class I antigens in pregnant womenMarlies K A Dankers, Dave L Roelen, Nelleke Korfage, et al.

Annals of the Rheumatic Diseases|August 14, 2012

Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitisFloris A van Gaalen, Willem Verduijn, Dave L Roelen, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2022

Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot StudyAnnelies E de Weerd, Zainab Al Fatly, Marieken Boer-Verschragen, et al.

Frontiers in Genetics|November 1, 2023

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactionsLisanne E N Manson, Sander J Delwig, Jos J M Drabbels, et al.

Human Immunology|January 1, 2004

The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigensMarlies K A Dankers, Dave L Roelen, Nico J D Nagelkerke, et al.

Clinical Science (London, England : 1979)|December 15, 2007

Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysmJan H N Lindeman, Hazem Abdul-Hussien, Alexander F M Schaapherder, et al.

HLA|February 26, 2023

HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapySuzanne Bezstarosti, Soufian Meziyerh, Marlies E J Reinders, et al.

Transplantation|November 20, 2002

Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failureCorine A van Kampen, Dave L Roelen, Minke F J Versteeg-van der Voort Maarschalk, et al.

Pageof 14